Seeking Alpha

The Supreme Court is due to hear arguments today on whether it's possible to patent isolated...

The Supreme Court is due to hear arguments today on whether it's possible to patent isolated human genes in a debate that encompasses the concept that IP can't cover "laws of nature." The case involves Myriad Genetics (MYGN), which holds two patents that allow it to genetically screen those at risk of breast or ovarian cancer. The impact of any ruling on the human-gene field will probably be limited, although it could have ramifications for the wider pharmaceuticals sector, agriculture, industrial microbiology and alternative fuels.
Comments (1)
  • doc47
    , contributor
    Comments (1014) | Send Message
     
    This is bad science fiction. Did they patent the idiot gene? Any court that lets these "patents" hold, should be lynched on the spot!
    16 Apr 2013, 12:10 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|